why choose us

First received: September 22, 2023

Clinical Trial: A Study to Evaluate Changes in Hair in Adult Participants Taking Oral Oriahnn Capsules With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Uterine Fibroids (UF)

Study Type: OBSERVATIONAL


Official Title: A Prospective, Single-Arm, Descriptive Observational Study to Evaluate Changes in Hair in Women Exposed to Oriahnn® (Elagolix 300 mg BID With Estradiol 1 mg/Norethindrone Acetate 0.5 mg QD)

Brief Summary: Uterine Fibroids (UF) are benign smooth muscle neoplasms of the uterus that affect women of reproductive age.UFs are one of the leading causes of hospitalizations for gynecological disorders and often lead to hysterectomy.In this study, women with heavy menstrual bleeding (HMB) due to UF who are being treated with Oriahnn will be followed to establish the incidence rate, time to onset, extent, pattern, and resolution of meaningful hair loss, as well as any racial differences.Oriahnn is an approved drug for the…

Read more